MAEL expression links epithelial‐mesenchymal transition and stem cell properties in colorectal cancer. Issue 11 (29th August 2016)

• Record Type: Journal Article
• Authors: Li, Qingguo; Wei, Ping; Huang, Ben; Xu, Ye; Li, Xinxiang; Li, Yaqi; Cai, Sanjun; Li, Dawei
• Is Part Of: International journal of cancer. Volume 139:Issue 11(2016:Dec. 01)
• Page Start: 2502
• Page End: 2511
• Publication Date: 2016-08-29
• Subjects: MAEL -- colorectal cancer -- epithelial‐mesenchymal transition -- stemness; Cancer -- Periodicals; Cancer -- Prevention -- Periodicals; 616.994
• DOI: 10.1002/ijc.30388
• Languages: English
• ISSNs: 0020-7136

Abstract

Abstract : MAEL plays a central role during spermatogenesis by repressing transposable elements and preventing their mobilisation, however, its role on cancers is unclear. In this study, MAEL expression was analysed in a tissue microarray containing 185 samples of primary colon cancer tumor samples and human colon cancer cell lines. The effect of MAEL on cell proliferation, tumorigenesis, metastasis and drug resistance was examined in vitro and in vivo . Immunoprecipitation assay, confocal immunofluorescent analysis and luciferase assay were used for mechanism study. As results, MAEL was significantly upregulated in colon cancer patient tissue samples, and elevated MAEL protein levels positively correlated with overall survival and disease free survival of colon cancer patients. Using in vitro and in vivo models, we demonstrated that MAEL expression was correlated with cell proliferation, invasion and drug resistance of colon cancer cells by inducing epithelial‐mesenchymal transition and stemness characteristics. Mechanistically, our study demonstrated that MAEL interacts with Snail and inhibit E‐cadherin promoter activity. Collectively, MAEL is an oncogene that plays an important role in the development and progression of colon cancer, which may be a novel potential therapeutic target for colon cancer. Abstract : What's new? The MAEL protein plays a central role in germline integrity and is normally only detected in the testis. MAEL is also abnormally expressed in various cancer tissues and cell lines; however, its role remains controversial. This study found that MAEL was frequently up‐regulated in colorectal cancer and may serve as a biomarker for prognosis. In in vitro and in vivo models, MAEL expression was correlated with cell proliferation, invasion and drug resistance of colon cancer cells by inducing the epithelial‐mesenchymal transition (EMT) and stemness characteristics. The authors also demonstrated that, mechanistically, MAEL interacts with Snail and inhibit E‐cadherin promoter activity.